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Tumor necrosis factor-a (TNF-a) is a potent inhibitor 
of connective tissue formation. The cellular effects of 
TNF-a are mediated by two distinct cell-surface re-
ceptors, TNF-R55 and TNF-R75, both present on 
various types of cells, including fibroblasts. In this 
study we wanted to elucidate the role ofTNF-R55 as 
a mediator of the connective tissue effects of TNF-a 
by using a mutant, TNF-R55-specific form ofhuman 
TNF-a. This mutant TNF-a markedly induced colla-
genase and strmnelysin-1 gene expression in dermal 
fibroblasts, the maximal activation (up to 42-fold) 
,• being 65%-89% of that noted with wild-type human 
r TNF-a. In addition, TNF-R55-specific TNF-a sup-
pressed type I collagen mRNA levels as potently as 
E xcess ive accumulation of type l coll agen results in tissue fibrosi s in disorders such as scleroderma, ke loids, and pulmonary fibrosis [1,2] . Deposition of type I collagen is regula ted by a numbe r of polypeptide growth fac tors [3] . The most potent stimulator of 
connective-tissue formation is transform in g growth factor-/3 (TGF-
{3), which enh ances expression of type l collagen genes at tran scrip-
tional level [ 4,5]. 
Tumor necrosis factor- a (TN F- a) is a pro-inflammatory cytokine 
that potently inhibits type I collagen and elastin gene expression at 
transcriptiona l level and is ab le to abrogate the activation of these 
gen es by TGF-/3 [5-10] . In addition , TN F- a stimulates degradation 
of extracellular matrix by enhan cing the expression of matrix 
metalloproteinases (MMPs), inte rsti ti al collagen ase (MMP-1), and 
stromelysin-1 (MMP-3) by fibroblas tic cells [11,12] . CoUagenase is 
th e only fibrob last proteinase capabl e of degrading native fibrillar 
coll agens, including type I and LH, in the extracellular space (see 
(12]). Coordinate induction of collagenase and stromelysin-1 is 
important for degradation of collagenous extracellular matrLX, 
because stromelysin is required for maximal activation of latent 
collagenase [1 2]. 
The cellul ar effects of TN F-a are m ediated via two distinct cell 
surface receptors, which both have recently been cloned [1 3-1 6]. 
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wild-type TNF-a (by 60%). The enhancement of col-
lagenase gene expression by TNF-R55-specific 
TNF-a was augmented by simultaneous treatment of 
normal and scleroderma skin fibroblasts with inter-
feron-y, indicating specific enhancement of TNF-
R55 signaling pathway by interferon-y. These results 
show that stimulation of the TNF-R55 signaling path-
way is sufficient for the inhibitory effects ofTNF-a on 
extracellular matrix formation by dermal fibroblasts. 
It is conceivable that due to reduced systemic toxic-
ity, TNF-R55-specific forms of human TNF-a may 
prove to be feasible in the therapy of fibrotic disor-
ders. Key words: sti'Omelysinlfibmsislscleroderma/inteifemll. 
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The p55 receptor (TNF-R55) is ex:pressed by various types of cells, 
inclucling epithelia l and fibroblastic cells [1 3, 14]. T h e p75 receptor 
(TNF-R75) is also expressed by numerous types of cells, especially 
by those of h em atopoietic lineage, as well as b y fibroblasts [1 6]. 
Systemic toxicity ofTNF-a appears to b e mediated b y TNF-R75, 
as demonstrated by the lower toxicity present in the human TN F- a 
in mice as compared to murin e TNF-a. T his appears due to lack of 
binding of human T NF-a to murine TNF-R75 [16 ,17). Presently, 
the ro le of diffe rent T NF-receptors in m ediating the connective 
ti ssue e fl:ects of T NF-a has not been es tablish ed. 
In this study we utilized a mutant, TNF-R55-specifi c fonn of 
human TNF-a, shown to be cytotoxic against malignant cells espe-
ciall y in combination witl1 IFN--y [18]. We show that T NF-R55-
specific TNF-a potently induces collagenase and strom elysin-l gen e 
expression ;md suppresses expression of type I collagen mRNA by 
human skin fibroblas ts. The effect of T NF-R55-specific T NF-a on 
collagenase gene expression is potentiated by simultan eous exposure 
of cells to IFN--y. These results suggest that T NF-R55 specific forms 
of TN F-a may offer a novel approach for treatment of tissue fibrosis 
by enhancing tun10ver of fibrotic collagenous connective tissue . 
MATERIALS AND METHODS 
Cell Cultures Normal human skin fibroblast cultures were established 
from punch biopsy obtained from a voluntary healthy male donor age 28 
years. In addition, fibrobla sts were cul tured fi·om lesional and healthy skin 
of a patient with system.ic scleroderma (female. age 37 years). CeU cultures 
were maintained in Dulbecco's modified Eagle's medium (DMEM) supple-
mented with 1 0'% fetal bovine serum (FBS). 2 mM glutamine, 100 IU/ ml 
peniciUin-G, and 100 J.tg/ml of streptomycin. For experiments, ce ll cultures 
were maintained in culture medium supplemented with 1% or 1 O'Vo FBS for 
18 h. T hereafter, T NF-R55-spccific human T NF-a (double mutant 
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R3 2WS86T) [19) or wild type human TNF-a were added in the concen-
trations indicated, and incubations were continued for 24 h . In some 
experiments, human recombinant IFN-y (from Boehringer Mannheim, 
Indianapolis, IN) (1000 U / ml) was added to the cultqre medium either 6 h 
before or simultaneous with TNF-a . 
RNA Analysis Total cellular RNA was isolated from cell cultures using 
the guanidine thiocyanate/cesium chloride method [20). Aliquots of total 
RNA (10 or 15 J.Lg) were fractionated on 0.8% agarose gels containing 2.2 
M formaldehyde and transferred to Zeta probe filters (BioRad, Richmond, 
CA) by vacuum transfer (VacuGene XL, LKB, Bromma, Sweden) and 
immobilized by heating at 80°C for 30 min . The filters were pre-hybridized 
for 2 h and subsequently hybridized for 20 h with cDNAs labeled by 
[a - 32P]dCTP using random priming. The filters were then washed, the final 
stringency being 0.1 X sodium citrate/sodium chloride buffer/0 .1% sodium 
dodecylsulfate at 60°C [21). The cDNA-mRNA hybrids were visualized by 
autoradiography, and the levels of mRNAs were quantitated by scanning 
densitometry of the x-ray films using MCID software (Imaging R esearch 
Inc., St. Catharines, Ontario, Canada). The following cDNAs were used for 
hybridizations: for collagenase, a 2.0-kb human eDNA [22] ; for stromely-
sin-1, a 1.5-kb human eDNA [23]: for tissue inhibitor of metalloprotein-
ases-1 (TIMP), a 0.7-kb human eDNA [24]; for proal (!) collagen, a human 
0.7-kb eDNA [25]; and for glyceraldehyde-3-phosphatc dehydrogenase 
(GAPDH), a 1.3-kb rat eDNA [26). 
Assay of Collagenase Production To measure the secretion of colla-
genase into the culture media the cells were maintained in serum-free 
DMEM for 18 h . Thereafter, TNF-RSS-specific or wild-type TNF-a (20 
ng/ml) was added either alone or in combination with IFN-y (1 000 U/ml) , 
and the incubations were continued for 24 h . The conditioned media were 
collected and the amount of collagenase was determined by Western 
immunoblotting [27) . Briefly, equal aliquots of medium samples were 
fractionated on SDS-polyacrylamide gel electrophoresis (PAGE) with 4% 
stacking and 7.5% resolvi.ng gels [28] and transferred to nitrocellulose 
membrane (Schleicher & Schuell, Dassel, Germany). The membrane was 
blocked with 5% (w/v) milk powder in phosphate-buffered saline (PBS) for 
1 .5 h. Subsequently it was incubated for 2 h w ith the primary antibody, a 
polyclonal rabbit antiserum against human fibroblast collagenase (kindly 
provided by Dr. H . Birkcdai-Hansen, University of Alabama , Birmingham, 
AL), in a 1 :200 dilution in milk/ PBS. T hereafter , the membrane was rinsed 
three times for 1 0 min with milk/ PBS, and peroxidase-conjugated swine 
anti-rabbit antibody (Dakopa tts, Glostrup, Denmark) was added in 1 :200 
dilution in milk/PBS for l h. T he membrane was rinsed three times with 
mHk/PBS, balanced in 50 mM Tris-HCl (pH 7.6), and developed with the 
solution containing 0.06% (w/v) diaminobenzidine, 50 mM Tris (pH 7.6), 
0.03% (v/ v) hydrogen peroxide, and 0.03% (w/v) CoC12 . T he levels of 
collagenase were quantitated by densitometric scanning of the filter and 
corrected for cell number detern1ined by the crystal violet staining method, 
as described previously [29] . 
RESULTS 
Suppression of type I Collagen and Induction of Collage-
nase and Stromelysin-1 mRNA Levels by TNF-RSS Specific 
TNF-a To evaluate the role of TNF-RSS as mediator of the 
inhibitory e ffect of TNF-a on connective tissue formation, normal 
human skin fibroblasts were incubated for 24 h with various 
concentrations of e ither wild- type human TN F-a or with mutant, 
TNF-R55-specific human TNF-a. The levels of proal(!) collagen, 
collagenase, strome lysin-1, and TIMP-1 mRNAs were then d e ter-
mine d by N o rthem blot hybridizations. In dermal fibroblasts 
maintained in DMEM supplemented with 1% FBS, I:NF-R55-
specific TNF-a potently reduced proal(!) collagen mRNA levels 
(Fig 1A). The maximal reduction (60%) noted was comparable to 
the inhibition obtaine d with wild-type TNF-a (Fig 1A,B). 
Rehybridization of the same filter with collagenase and strome-
lysin-1 cDNAs reveale d that both dose-dependent and max.imal 
activation of collagen ase and stromelysin-1 mRNA levels by TNF-
R55-specific TNF-a were somewhat lower than the level of 
induction obtained with wild-type human TNF-a (Fig 1A). T he 
max imal induction of collagenase mRNA levels (23-fold) obtained 
with concentration 10 ng/ml of TNF-RSS-specific TNF-0' was 
65% of the indu ction noted with the sa me concentration of 
wild-type TN F- a (Fig 1B). The maximal enhancement of strome-
lysin-1 mRNA abundance (eleve nfold), obtained with concentra-
t ion 100 ng/ ml of TNF-R55-specific TNF-a, was 61% of the 
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Figure 1. Dose-dependent suppression of proal(I) collagen and 
induction of collagenase and stromelysin-1 mRNA levels by TNF-
RSS--specific TNF-a in dermal fibroblasts. A ) ConAuent human skin 
fibrobla st cultures maintained in DMEM supplemented with 1% FBS were 
treated with various concentrations of wild-type TNF- a (wTTNF-a) or 
TNF-R55-specific TNF-cr (MTNF-a) for a period of 24 h . Levels for 
proa l(!) collagen, coLlagenase, stromelysin-1 , T lMP-1 , and GAPDH 
mRNA were measured by N orthern blot hybridizations. B) Quantitation of 
proal (I) collagen , collagenase, stromelysin-1 , and TIMP-1 mRNA levels 
from ceLl s treated with various concentrations of wild-type TN F-a (D) or 
TNF-R55-specific TNF-a (e), by densitometric scanning of the x-ray films 
in A. The mRNA levels were corrected for GAPDH mR.NA levels in the 
same RNA samples. 
level noted with wild-type TNF-a (Fig 1A,B). ln the same samples, 
mRNA abundance ofTIMP-1, the natural inhibitor of collagenase 
and stromelysin-1 activity, was not marke dly alte red by either 
wild-type or TNF-RSS-specific TNF-a (Fig 1A,B). The levels of 
glyceraldeh yde-3-phosphate dehydrogenase (GAPDH) mRNA re-
mained unaltered by treatment with both forms ofTNF-a. 
IFN-y Augments TNF-R55-Mediated Induction of Collag-
enase mRNA Abundance and Production By TNF-a It has 
been shown that IFN-')' potentiates the inhjbitory e ffect of TN F-a 
o n type I collagen gene expression in human skin fibroblasts [5,8]. 
It was also recently reported that the cytotoxic e ffect ofTNF-R55-
specific TNF-a on malignant human cells is augmented by IFN-')', 
indicating specific pote ntiation of TNF-RSS signaling pathway by 
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Figure 2 . IFN-y augments induc tion of c ollagenase mRNA levels 
by TNF-a. A) ConAucnt human skin fibroblasts maintained in DME M 
supplemented with I 'X, FBS were treated with wi ld-type TN F-a 
(WTTNF-a) or TNF-RSS-specific TNF-a (MTNF-a) (20 ng/ml) for a 
period of 24 h. Certain culntres were pretreated with IFN-y (1000 U/ml) 
for 6 h before addition of TN F-a, as indicated. Leve ls for collagenase and 
T IMP-1 mRNA were measured by Northern blot hybridizations. lSS and 
28S rRNAs were visualized by ethidium bromide staining . B) Q uantiwtion 
of collagenase mR.NA levels by densitometric scanning of the x-ray fi lm in 
A. Collagenase mRNA levels were corrected for the amount of rR.NA in 
the same .RNA samples . 
IFN- y [18). In this context w e wanted to investigate the effect of 
IFN-y on T N F-a- elicited induction of collagenase gen e expression 
in human skiJ1 fi brob lasts. In the ini tia l experim ent, human skin 
fibroblasts m aintain ed in 1% FBS were preincubated w ith IFN-y 
(1 000 U/ml) for 6 h before addition ofTNF-a. After an additio nal 
24-h incubation w ith either T N F-RSS-specific or w ild-type human 
TN F-a (20 ng/ml each) , mRNA leve ls for coll agenase and TIMP-1 
were d e termined. Incubation of cell s with IFN-y alone had n o 
effect on collagenase mRNA abundance (Fig 2A) . A s noted above, 
TNF-RSS-specifi c T N F- a m arkedly induced collagen ase mRNA 
levels, the level of induction (forty-two-fold) in this experiment 
being 89% of the activation noted with wild-type TNF-a (Fig 
2A,B) . Interestingly, a 6-b pre-inc ubatio n w ith IFN-y clearly 
augmented the enhancem ent of colla genase mRNA levels by both 
form s of T NF-a (Fig 2A) . Quantitation of the mRN A levels and 
correction for the amount of rRNA i.n each sample indicated that 
IFN-y augmented induction of coll agen ase mRNA levels fi·om 
fo rty-two- fold to sixty-three- fo ld with TNF-R.SS-specific T NF-a, 
and from forty- eight-fold to sixty-three-fold with w ild- type T N F-a 
(Fig 2B). Because the combination ofTN F-a and IFN-y appeared 
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Figure 3 . IFN-y a ugments induction of collagenase production by 
TNF-a. A ) ConAuent human skin fibrobla st cultures maint:lined in serum 
!Tee DMEM were trea ted with wild-type T N F-a (wTTNF-a) or TNF-RSS-
specific TN F-a (MTNF-cr) (20 ng/ ml) for a period of24 h. Certain cultures 
were pretreated with IFN-y (1 000 U/ ml) for 6 h before addition ofTNF-a, 
as indicated. Levels of co llagenase in the condi tioned media were assayed by 
Western blotting using an antico llagcnasc antiserum . The migration posi-
tions of mol ecular weight markers (M, X 1 0- 3 ) arc shown on the left. B) 
Q uantitation of collagenase production by densitometry of the Western blot 
in A. Collagenase production for each sample was corrected for cell 
number. 
to enhance GAPDH mR.NA abundance (data not shown), mRNA 
levels were corrected for the amoun t ofrRNA in all eA.lJerim en ts in 
w hich a combinat ion of T N F-a and IFN-y was used. 
To examine w heth er co-treatment of dermal fibroblasts w ith 
TN F-a and IFN- y also resu lts in increased production of collage-
nase, we d e termined the am o unt of coll agenase in the conditioned 
m edia with W este rn blotting using an anti- collagenase antisenun . 
In this experiment TNF-RSS-specific T N F- a enhanced collage-
n ase production as potently (e ighteen fo ld) as wild-type TNF-a 
(nineteenfold). Six-hour pretreatment w ith JFN-y furth er increased 
collagenase produ ction up thi rry-two fo ld in combination w ith 
TNF-RSS-specific TNF-a and forty-four-fo ld w ith wild-rype 
T NF-a (Fig 3A,B) . IFN-y alo n e had no effec t on collagen ase 
production (Fig 3A,B) . Taken together , these results indicate that 
IFN-y specifically augments T NF-RSS-m ediated signaling path-
way resulting in further induction of coll agenase gene expression. 
The enhancing effect of i FN-y could be d ue to an increase in the 
number of T N F-a receptors during the 6-h pretreatment period 
with IFN-y [30] . In the next expe1iment we examined w heth er a 
6-h pretreatment with IFN -y is required for augmentation of 
collagen ase mRNA induction by T NF-RSS-specific TN F-a. In this 
experiment, !FN-y (1000 U / ml) potently augmented induction of 
coll agen ase ml~A abundance by TNF-RSS-specific T N F- a from 
thirteen to twentyfold, both with o r without a 6-h p(etreatm ent 
(Fig 4) . As noted above, treatment of derm al fibrob lasts with 
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Figure 4. Effect ofiFN-y pretreat~ent length on augmentation of 
coUagenase mRNA induction by TNF-a. Confluent human skin 
fibroblast cul tures maintained in DMEM supplemented with l O'X. FBS were 
treated with TNF-RSS-specific TN F-a (MTNF-a) (20 ng/ml) for a period 
of 24 h. To certain cultures, IFN-y (J 000 U/ml) was added e ither 
simultaneously (0 h) , or 6 h before (- 6 h) addition ofTNF-a. Levels for 
co Llagenase, stromelysi11-1, and TIMP-1 m:RNA were measured by North-
ern blot hybridizations. 18S and 28S rR.NAs were visuali zed by cthidium 
bromide stai ning. 
IFN-')' alone had no effect on collagenase mRNA abundance 
regardless of the duration of incuba tion. T he levels ofstromelysin-1 
mRNA were s)jghtly reduced in cultures treated with IFN- ')' alone . 
In adrution, IFN-')' inhibited enhancement of stromelysin-1 mRNA 
levels by TNF-RSS-specific TNF-a (Fig 4). T he levels ofTIMP-1 
mRNA remained unal tered by T NF-a, IFN-')', or both (Fig 4). 
Induction of Collagenase mRNA Levels By TNF-R55 Spe-
cific TNF-a In Scleroderma Fibroblasts It was recently re-
ported that fibrob lasts cultured fi·om fibrotic skin of patients with 
systemic scleroderma produce reduced amoun ts of collagenase as 
compared to control skin fibroblasts [31]. In this context we 
examined w hether TNF-RSS-specific TN F-a is capable of enhanc-
ing collagenase expression in fibroblasts cultured from lesionaJ and 
healthy skin of a patient with systemic scleroderma. Treatment of 
sderoderma skin fibroblasts with TNF-RSS-specific TNF-a re-
sulted in thirteenfold enhancem ent in collagenase mRNA levels 
(Pig 5). Simultan eous treatL"llent of scleroderma skin fibroblasts 
with TNF-a and IFN-')' fi.uther augmented collagenase mRNA 
levels up twentyfold as compared to the untreated sc!eroderma 
fi broblasts. CoiJagenase mRNA levels in healthy skin fibroblasts 
were also induced by TNF-RSS-specific TN F-a by sevenfold, and 
the activation of collagenase mRNA abundance was augmented up 
fourteenfold by simultaneous treatment of fibroblasts with lFN-')' 
(Pig 5). The basal collagenase mRNA levels were equa!Jy low in 
both scleroderma and healthy skin fibroblasts. TIMP-1 mRNA 
levels were not altered by any of the treatments (Fig 5) . These 
results indicate that scleroderma fibroblasts are susceptible to 
induction of collagenase gene expression by TN F-a via TNF-R55, 
and that IFN-')' potentiates this signa ling pathway. 
DISCUSSION 
The results of tlus study show that a mutant, TNF-R55-specific 
human TNF- a induces collagenase .and stromelysin-l gene expres-
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Figure 5. TNF-RSS-specific TNF- a induces collagenase mRNA 
levels in scleroderma skin fibroblasts. Human skin fibroblasts from 
normal (NA) or lcsional (PSS) skin of a patient with systemic scleroderma 
were treated with TNF-RSS- specific TNF-a (MTNF-a) (20 ng/ml), alone 
or in combination with IFN-y (1000 U/ml) in DMEM with 1% FBS for 24 
h . Collagenase and T IMP-1 mRNA levels were measured by Northern blot 
hybridizations. 18S and 28S rR.NA were visualized by eth.idium bromide 
sta ining. 
sion in human dermal fibroblasts nearly as potently as wild-type 
human T NF-a. The maximal activation of collagenase gene ex-
pression by T NF-RSS-specific T NF-a was obtained with a higher 
concentration (1 0 ng/m l) than with wild-type TNF-a (1 ng/ml) . 
This is most Likely due to slightly lower binding affinity of the 
mutant (R.32WS86T) TNF-a to TNF-RSS, as compared to wild-
type TNF- a [1 9,32] . However, we cannot excl ude the possibility 
that TNF-R75 alone or its interaction with TNF- RSS is required 
for nuximal induction of gene expression via TNF-RSS, because a 
difference in collagenase and stromelysin-1 mRNA levels was 
noted even with the highest TNF-a concentrations used--up to 
100 ng/ml (Fig 1). In contrast, T N F-RSS- specific TNF- a inhibits 
type I collagen gene expression as potently as wild-type T NF-a. 
T hese results indicate that stimulation of the TNF-RSS signaling 
pa thway is sufficient for the inhibitory effects of TNF-a on extra-
cellu lar matrix formation by dermal fibroblasts. 
Previously, IFN-')' has been shown to potently suppress type I 
and type III collagen gene expression by normal and scleroderm a 
skin fibroblasts in culture [33,34]. In addition, IFN-')' potently 
prevents formation of tissue fibrosis in a mouse model [35] , and 
potentiates the inlubitory effect of TN F-a on type I co!Jagen gene 
expression (5,8]. IFN-')' has been used in the treatment of systemic 
scleroderma with variable results [36,37]. Furthermore, local ad-
ministration of IFN-a and IFN-')' in ke loids results in clinical 
improvement and normalization of collagen and collagenase pro-
duction in 11itro [38,39] . The results of tlus study show that JFN-')' 
alone does not induce expression of collagenase gene by dermal 
fibroblasts. Thus, it is likely that IFN-')' is most effective in the early 
stage of tissue fibrosis, in which excessive synthesis of collagen still 
takes place. Our observations provide evidence that simultan eous 
exposure of normal and scleroderma skin fibroblasts to IFN-y and 
TNF-RSS-specific TNF-a augments induction of collagenase gene 
expression by TN F-a. It is conceivable that combination of IFN-')' 
with TNF-RSS-specific T NF-a may result in enhanced turnover of 
the fibrotic collagenous extracellular m atrix in the later stage of 
tissue fibrosis, in which excessive deposition of type J collagen has 
already occurred. 
Previous studies have shown that IFN-')' suppresses collagenase 
expression by ma crophages [40] and abrogates induction of colla-
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genase production by TN F-a in synoviocytes [ 41 ] and by interleu-
kin-1 in chondrocytes f 42]. O ur resu lts show that in human skin 
fibroblasts IFN--y augments induction of co llagenase gene expres-
sio n by TNF-R.SS-specifi c TNF-a at mRNA and at the protein 
level in severa l independent experi m ents w ith three different skin 
fib robl ast lin es. It is likely that the effect of IFN--y o n collagenase 
gene expressio n is dependent on ce ll type, as demonstrated recently 
by th e ability of I FN--y to induce collagenase expression in epider-
mal keratinocytes [43]. It is unukcly that the potentiating effect of 
IFN--y on coll agenase expressio n in ski n fibro blasts could be due to 
an increase in TNF-RSS expression l30], because this effect was not 
dependent on a 6-h p•·etreatment with !FN--y. Furthermore, simul-
taneous incubation of fibroblasts with IFN--y and TN F-a did not 
augmen t induction of c-j 1111 and c-Jos mRNA leve ls by TN F-a (data 
not shown). Another explanation for the effect of !FN--y o n 
induction of co llagenase gene expressio n co uld be crossta lk be-
tween TNF-RSS-mediatcd and IFN--y signa ling pathways . Re-
cently, it has been shown that cellular IFN- -y response involves 
p hosphorylation ofSTATl-a and STAT1-f3 transcription f.,cto rs by 
a m echani sm that requires activity of JAK1 and JAK2 tyros in e 
k:inases [ 44-46]. However, the role of this I FN--y signaling path-
way in the regulatio n of co lla genase gene expression has not yet 
been elu cidated. 
We ha ve recently shown that induction of collagenase gene 
expression by TNF-a, interleukin-1, and phorbol esters is potenti-
ot ated by cyclosporin-A in no rmal and scleroderma skin ftbroblasts 
[ 4 7]. T his effect appears to be due to prolonged induction of c-j1111 
expressio n. T his o bservation provides o ne explanation for the 
beneficial effect of cyclosporin-A in the treatment of systemic 
scleroderm a (sec [2]). It is likely that in addition to inhibition of 
excessive connective tissue formation, a loca l and con trolled stim-
ulation of extracellular m atrix tumovcr m ay o ffer a novel fon11 of 
treatment for resolving tissue fibrosis. 
In summary, o ur results indicate that stimulatio n of T NF-R.S S-
media ted signalin g pathway is sufficient for the inhibitory effects of 
TNF- a on extra cellular m atrix formation by human skin fibro-
b lasts. It is conceivable that due to lack of systemic tox-icity, 
TNF-RSS-spccific fom1s of human TNF-a may prove to be 
feasib le in therapy of fibrotic disorders, especiall y in combination 
with IFN--y. On the oth er hand , specifi c inhibition of TNF-RSS-
signa ling pathway may prove to be feasible in infl ammatory con-
ditions characterized by excessive con nective tissue degradation , 
such as rheumatoid arthri tis and periodontitis [12]. Unveiling the 
molecular mechanisms ofTNF-RSS-signaling pathway is likely to 
yie ld information that will be beneficial i.n the development of 
novel therapeutic m odalities for these disorders. 
Tit is study II'IIS .fiucutcinlly supp011cd by .~rnuts jimu tltc Paulo Fmmdntiou, Turk u 
Uuiv<~·sity Pmuulntiou, Sigridjusl:lius Fmmdntic>ll, n111l tlte Cnuccr Research Pm mdotiou 
cif So11tlul'cstent Finlmul (V-MK) cmd.Jimu Turku Uuit•tnit)> Socict)> UW). 
Hl'e tl11111k Ms. Mnritn Potiln .Ji•r skilljitl tcclmicnl nssistnucc, n111l Dtc<. E. Bauer, 
M. Kurkiueu , D. C mmiclt ncl, E. Vuorio, nurl P. Pm·t .for plnsmirls. f¥c nrc also 
grntiful to Dr. Jyrki Heiuo .for rliswss ious. 
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